James Clemmer AngioDynamics CEO Rating
Where This Score Ranks AngioDynamics' CEO Rating
- BOTTOM5%
In the Bottom 5% of 2126 Similar Sized Companies on Comparably
- 3rd
3rd place versus 2 competitors rated on Comparably
AngioDynamics CEO James Clemmer Bio
Mr. James C. Clemmer, also known as Jim, has been Chief Executive Officer, President and Director of AngioDynamics Inc. since April 04, 2016. Mr. Clemmer served as Group President of the Kendall Healthcare division of Covidien from June 2004 to September 2006, where he managed the US business across five divisions and built the strategic plan for the Medical Supplies segment before it was spun off from Tyco. In addition, he managed global manufacturing, research and development, operational excellence, business development and all other functions associated with the Medical Supplies business. Mr. Clemmer is a seasoned industry executive with more than 25 years of operational, manufacturing, marketing and business development experience with global healthcare product companies. He directed the strategic and day-to-day operations for global business divisions that collectively manufactured 23 different product categories. He served as the President of Medical Supplies and Senior Vice President of Covidien plc since October 2006 and November 2009 respectively. He began his career in the medical device industry with Sage Products, Inc., joined Covidien as part of the Sage Products acquisition in 1999. He served as the President of the SharpSafety and Critical Care Divisions of Covidien from June 2001 to June 2004. He served as Vice President and General Manager of the SharpSafety division of Covidien from March 2001 to June 2001. He has been a Director of Lantheus Holdings, Inc and Lantheus Medical Imaging, Inc. since July 9, 2015. He serves as a Trustee at Massachusetts College of Liberal Arts. Mr. Clemmer is a Graduate of the Massachusetts College of Liberal Arts.
AngioDynamics CEO James Clemmer At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at AngioDynamics.
Based on 10 ratings, James Clemmer ranks right below CryoLife's CEO, J. Patrick Mackin.
Overall, the CEO score has remained stable over the last 90 days.
AngioDynamics CEO James Clemmer Rating Trendline
- AngioDynamics40
- Similar Size on Comparably
AngioDynamics' CEO Rating Rank Against Similar Sized Companies on Comparably
AngioDynamics ranks in the Bottom 5% of other companies on Comparably with 1,001-5,000 Employees for CEO Rating Score.
